These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2284886)

  • 1. Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism.
    Giustina A; Ferrari C; Bodini C; Buffoli MG; Legati F; Schettino M; Zuccato F; Wehrenberg WB
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):613-8. PubMed ID: 2284886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients.
    Ramos-Dias JC; Lengyel AM
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):461-7. PubMed ID: 10583313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hyperthyroidism on growth hormone secretion.
    Valcavi R; Dieguez C; Zini M; Muruais C; Casanueva F; Portioli I
    Clin Endocrinol (Oxf); 1993 May; 38(5):515-22. PubMed ID: 8330446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Buffoli MG; Bussi AR; Wehrenberg WB
    Horm Res; 1991; 36(5-6):192-5. PubMed ID: 1823078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone.
    Ramos-Dias JC; Yateman M; Camacho-Hübner C; Grossman A; Lengyel AM
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):583-9. PubMed ID: 8548943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Bussi AR; Legati F; Bossoni S; Licini M; Schettino M; Zuccato F; Wehrenberg WB
    Acta Endocrinol (Copenh); 1992 Dec; 127(6):504-8. PubMed ID: 1283476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism.
    Lee EJ; Kim KR; Lee HC; Cho JH; Nam MS; Nam SY; Song YD; Lim SK; Huh KB
    Metabolism; 1995 Nov; 44(11):1509-12. PubMed ID: 7476342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy.
    Kuo SW; Huang WS; Hu CA; Liao WK; Fung TC; Wu SY
    Eur J Endocrinol; 1994 Aug; 131(2):125-30. PubMed ID: 8075781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism.
    Giustina A; Schettino M; Bussi AR; Legati F; Licini M; Zuccato F; Wehrenberg WB
    Horm Res; 1992; 38(5-6):256-9. PubMed ID: 1307747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism.
    Ramos-Dias JC; Pimentel-Filho F; Reis AF; Lengyel AM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1343-6. PubMed ID: 8636330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thyroid status on the growth hormone response to growth hormone releasing hormone 1-44.
    Davies RR; Dagogo-Jack S; Turner SJ; Kendall-Taylor P; Baylis P; Young E; Watson M; Johnston DG
    J Endocrinol Invest; 1989 Sep; 12(8):517-21. PubMed ID: 2512339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
    Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.